Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation

Study identifier:D5257L00014

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation for long-term use in Pediatrics

Medical condition

Bronchial Asthma

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

633

Study type

Observational

Age

6 Months - 5 Years

Date

Study Start Date: 01 Oct 2006

Primary Completion Date: 01 Jul 2011

Study Completion Date: 01 Jul 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Pulmicort Respules Those with an exposure	-

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=498&filename=CSR-D5257L00014.pdf
Download
CSR-D5257L00014.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information

Miyo.Ishihara@astrazeneca.com

Investigators

Principal Investigator

Yoshida Shigeru

AstraZeneca K.K.